BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37931208)

  • 1. TCR Pathway Mutations in Mature T Cell Lymphomas.
    Zhang Y; Cheng K; Choi J
    J Immunol; 2023 Nov; 211(10):1450-1458. PubMed ID: 37931208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin.
    Chiang AK; Srivastava G; Lau PW; Ho FC
    Hum Pathol; 1996 Jul; 27(7):701-7. PubMed ID: 8698315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rearrangement of the T-cell receptor delta chain gene in T-cell lymphomas with a mature phenotype.
    van Krieken JH; Elwood L; Andrade RE; Jaffe ES; Cossman J; Medeiros LJ
    Am J Pathol; 1991 Jul; 139(1):161-8. PubMed ID: 1830192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations affecting GTPases and T-cell receptor signaling in peripheral T-cell lymphomas.
    Boddicker RL; Razidlo GL; Feldman AL
    Small GTPases; 2019 Jan; 10(1):33-39. PubMed ID: 27898263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
    Fujisawa M; Sakata-Yanagimoto M; Nishizawa S; Komori D; Gershon P; Kiryu M; Tanzima S; Fukumoto K; Enami T; Muratani M; Yoshida K; Ogawa S; Matsue K; Nakamura N; Takeuchi K; Izutsu K; Fujimoto K; Teshima T; Miyoshi H; Gaulard P; Ohshima K; Chiba S
    Leukemia; 2018 Mar; 32(3):694-702. PubMed ID: 28832024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships among expression, transcription and rearrangement of T-cell receptor beta gene in T-cell lymphomas.
    Kasai K; Kameya T; Ono M; Wada C; Kuwao S; Motoori T
    Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):57-65. PubMed ID: 2163138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice.
    Liu X; Karnell JL; Yin B; Zhang R; Zhang J; Li P; Choi Y; Maltzman JS; Pear WS; Bassing CH; Turka LA
    J Clin Invest; 2010 Jul; 120(7):2497-507. PubMed ID: 20516645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.
    Wartewig T; Kurgyis Z; Keppler S; Pechloff K; Hameister E; Öllinger R; Maresch R; Buch T; Steiger K; Winter C; Rad R; Ruland J
    Nature; 2017 Dec; 552(7683):121-125. PubMed ID: 29143824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports.
    Rojansky R; Fernandez-Pol S; Wang E; Rieger KE; Novoa RA; Zehnder JL; Kunder CA; Kim YH; Khodadoust MS; Brown RA
    Diagn Pathol; 2020 Sep; 15(1):122. PubMed ID: 32988392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors.
    Klinger MB; Guilbault B; Goulding RE; Kay RJ
    Oncogene; 2005 Apr; 24(16):2695-704. PubMed ID: 15829980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disregulated expression of the transcription factor ThPOK during T-cell development leads to high incidence of T-cell lymphomas.
    Lee HO; He X; Mookerjee-Basu J; Zhongping D; Hua X; Nicolas E; Sulis ML; Ferrando AA; Testa JR; Kappes DJ
    Proc Natl Acad Sci U S A; 2015 Jun; 112(25):7773-8. PubMed ID: 26056302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of angioimmunoblastic T-cell lymphoma and related cancers].
    Sakata-Yanagimoto M
    Rinsho Ketsueki; 2019; 60(9):1221-1228. PubMed ID: 31597847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signals transduced by CD3epsilon, but not by surface pre-TCR complexes, are able to induce maturation of an early thymic lymphoma in vitro.
    Carleton M; Ruetsch NR; Berger MA; Rhodes M; Kaptik S; Wiest DL
    J Immunol; 1999 Sep; 163(5):2576-85. PubMed ID: 10452996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR-dependent transformation of mature memory phenotype T cells in mice.
    Wang X; Werneck MB; Wilson BG; Kim HJ; Kluk MJ; Thom CS; Wischhusen JW; Evans JA; Jesneck JL; Nguyen P; Sansam CG; Cantor H; Roberts CW
    J Clin Invest; 2011 Oct; 121(10):3834-45. PubMed ID: 21926465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell.
    Serwold T; Hochedlinger K; Swindle J; Hedgpeth J; Jaenisch R; Weissman IL
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18939-43. PubMed ID: 20956329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into the pathogenesis of T-cell lymphomas.
    Van Arnam JS; Lim MS; Elenitoba-Johnson KSJ
    Blood; 2018 May; 131(21):2320-2330. PubMed ID: 29666117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.
    Emile JF; Boulland ML; Haioun C; Kanavaros P; Petrella T; Delfau-Larue MH; Bensussan A; Farcet JP; Gaulard P
    Blood; 1996 Feb; 87(4):1466-73. PubMed ID: 8608237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.